The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Recruiting Phase 1 Interventional Study
Imipramine Photodynamic Therapy Actinic Keratosis
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Trial phase
Phase 1
Study type
Interventional
Purpose
Other
Participants needed
24 (estimated)
Sponsor
Wright State University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is testing the use of topical Imipramine in combination with topical photodynamic therapy's (PDT) effect on pain following treatment. PDT is a commonly used treatment in dermatology for patients who have many pre-cancers (actinic keratosis-AKs) on their skin. These are both FDA-approved treatments, but this study is evaluating their use in combination, which has not been …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Male or female ages 18 and older * Skin type must be "Fair", Fitzpatrick type I to III, due to the presence of actinic damage in this population. * Subjects need to have a physician's order to receive PDT treatment on their face, scalp or forearms. * Willing to participate and…
Contacts

Manager, Clinical Research Operations

937-245-7500

pturesearch@wrightstatephysicians.org

CONTACT

Regulatory Specialist

937-245-7500

pturesearch@wrightstatephysicians.org

CONTACT